Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The book starts with the editors’ preface summarizing the contributions of each of the following thirteen articles dealing with chemical and pharmacological aspects of the molecular modulators of the oxidative stress in regard to various therapeutic approaches in cardiovascular and neurodegenerative diseases, cancer, and diabetes. The seven articles present data from original research studies enlightening the roles and mechanisms of action of small molecular weight compounds (natural and synthetic; ascorbic acid/vitamin C, deferoxamine, N-acetylcysteine, MitoVitE, α-tocopherol, trolox, and ezetimibe) or proteins (SIRT3) in modulation of oxidative stress. In the six review papers, the authors present and discuss the possible therapeutic potential of novel approaches and compounds that are promising and deserve further investigation, in modulation of oxidative stress.

Research & information: general --- Biology, life sciences --- ascorbic acid --- deferoxamine --- N-acetylcysteine --- ischemia/reperfusion --- cardiac fibroblasts --- reactive oxygen species --- photobiomodulation --- reactive oxygen species (ROS) --- nuclear factor kappa-light-chain-enhancer of activated B cells (NF-кB) --- cancer --- diabetes --- wound healing --- glucose --- pentose phosphate pathway --- NADPH --- redox balance --- glycogen --- glycolysis --- stress resistance --- insulin resistance --- immunomodulation --- inflammation --- olive tree --- oxidative stress --- secoirioids --- sirtuin 3 --- high fat diet --- sex differences --- mice --- metabolic stress --- antioxidants --- ADHD --- Nrf2 --- NRF2-KEAP1 --- ROS --- cancer metabolism --- antioxidant --- cancer therapy --- chemoresistance --- radioresistance --- sepsis --- MitoVitE --- mitochondria --- gene expression --- cytokines --- mRNA --- vitamin C --- folic acid --- one-carbon metabolism --- C2C12 cells --- metabolomics --- mass spectrometry --- type 2 diabetes --- dipeptidyl peptidase-4 inhibitors --- biomarkers --- ER stress --- Ezetimibe --- ischemia-reperfusion --- ionizing radiation --- liver --- hydroperoxide --- epigenetics --- miR7/MAFG/Nrf2 axe --- ascorbic acid --- deferoxamine --- N-acetylcysteine --- ischemia/reperfusion --- cardiac fibroblasts --- reactive oxygen species --- photobiomodulation --- reactive oxygen species (ROS) --- nuclear factor kappa-light-chain-enhancer of activated B cells (NF-кB) --- cancer --- diabetes --- wound healing --- glucose --- pentose phosphate pathway --- NADPH --- redox balance --- glycogen --- glycolysis --- stress resistance --- insulin resistance --- immunomodulation --- inflammation --- olive tree --- oxidative stress --- secoirioids --- sirtuin 3 --- high fat diet --- sex differences --- mice --- metabolic stress --- antioxidants --- ADHD --- Nrf2 --- NRF2-KEAP1 --- ROS --- cancer metabolism --- antioxidant --- cancer therapy --- chemoresistance --- radioresistance --- sepsis --- MitoVitE --- mitochondria --- gene expression --- cytokines --- mRNA --- vitamin C --- folic acid --- one-carbon metabolism --- C2C12 cells --- metabolomics --- mass spectrometry --- type 2 diabetes --- dipeptidyl peptidase-4 inhibitors --- biomarkers --- ER stress --- Ezetimibe --- ischemia-reperfusion --- ionizing radiation --- liver --- hydroperoxide --- epigenetics --- miR7/MAFG/Nrf2 axe

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The book starts with the editors’ preface summarizing the contributions of each of the following thirteen articles dealing with chemical and pharmacological aspects of the molecular modulators of the oxidative stress in regard to various therapeutic approaches in cardiovascular and neurodegenerative diseases, cancer, and diabetes. The seven articles present data from original research studies enlightening the roles and mechanisms of action of small molecular weight compounds (natural and synthetic; ascorbic acid/vitamin C, deferoxamine, N-acetylcysteine, MitoVitE, α-tocopherol, trolox, and ezetimibe) or proteins (SIRT3) in modulation of oxidative stress. In the six review papers, the authors present and discuss the possible therapeutic potential of novel approaches and compounds that are promising and deserve further investigation, in modulation of oxidative stress.

ascorbic acid --- deferoxamine --- N-acetylcysteine --- ischemia/reperfusion --- cardiac fibroblasts --- reactive oxygen species --- photobiomodulation --- reactive oxygen species (ROS) --- nuclear factor kappa-light-chain-enhancer of activated B cells (NF-кB) --- cancer --- diabetes --- wound healing --- glucose --- pentose phosphate pathway --- NADPH --- redox balance --- glycogen --- glycolysis --- stress resistance --- insulin resistance --- immunomodulation --- inflammation --- olive tree --- oxidative stress --- secoirioids --- sirtuin 3 --- high fat diet --- sex differences --- mice --- metabolic stress --- antioxidants --- ADHD --- Nrf2 --- NRF2-KEAP1 --- ROS --- cancer metabolism --- antioxidant --- cancer therapy --- chemoresistance --- radioresistance --- sepsis --- MitoVitE --- mitochondria --- gene expression --- cytokines --- mRNA --- vitamin C --- folic acid --- one-carbon metabolism --- C2C12 cells --- metabolomics --- mass spectrometry --- type 2 diabetes --- dipeptidyl peptidase-4 inhibitors --- biomarkers --- ER stress --- Ezetimibe --- ischemia-reperfusion --- ionizing radiation --- liver --- hydroperoxide --- epigenetics --- miR7/MAFG/Nrf2 axe --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Refrigeration, air conditioning, and heat pumps (RACHP) have an important impact on the final energy uses of many sectors of modern society, such as residential, commercial, industrial, transport, and automotive. Moreover, RACHP also have an important environmental impact due to the working fluids that deplete the stratospheric ozone layer, which are being phased out according to the Montreal Protocol (1989). Last, but not least, high global working potential (GWP), working fluids (directly), and energy consumption (indirectly) are responsible for a non-negligible quota of greenhouse gas (GHG) emissions in the atmosphere, thus impacting climate change.

History of engineering & technology --- burnt-out diabetes --- chronic kidney disease (CKD) --- dialysis --- end-stage renal disease (ESRD) --- incident diabetes mellitus (DM) --- insulin resistance --- dementia --- dipeptidyl-peptidase IV inhibitors --- diabetes mellitus --- type 2 --- Alzheimer’s disease --- vascular --- diabetes --- microperimetry --- type 2 diabetes mellitus --- glucose fluctuations --- sarcopenia --- diabetic retinopathy --- type 1 diabetes --- quality of life --- treatment satisfaction --- patient-reported outcomes --- plaque characteristics --- carotid plaque --- echogenic plaque --- diabetic foot syndrome --- vascular disease --- fibroblast growth factor 23 --- Klotho --- inflammation --- dermal electrochemical conductance --- neuropathy --- primary care --- screening --- sudomotor reflex --- prediabetes --- arterial stiffness --- baPWV --- aspirin --- primary prevention --- meta-analysis --- trial sequential analysis --- sCD36 --- type 1 diabetes mellitus --- branched-chain amino acids --- metabolomics --- NMR spectroscopy --- diabetic kidney disease --- reno-cardiovascular protection --- sodium-glucose co-transporter 2 inhibitors --- glucagon-like peptide-1 receptor agonists --- dipeptidyl peptidase 4 inhibitors --- obesity --- bariatric surgery --- diabetic macroangiopathy --- cardiovascular disease --- heart disease --- cerebrovascular disease --- peripheral artery disease --- diabetic foot disease --- diabetic microangiopathy --- diabetic neuropathy --- burnt-out diabetes --- chronic kidney disease (CKD) --- dialysis --- end-stage renal disease (ESRD) --- incident diabetes mellitus (DM) --- insulin resistance --- dementia --- dipeptidyl-peptidase IV inhibitors --- diabetes mellitus --- type 2 --- Alzheimer’s disease --- vascular --- diabetes --- microperimetry --- type 2 diabetes mellitus --- glucose fluctuations --- sarcopenia --- diabetic retinopathy --- type 1 diabetes --- quality of life --- treatment satisfaction --- patient-reported outcomes --- plaque characteristics --- carotid plaque --- echogenic plaque --- diabetic foot syndrome --- vascular disease --- fibroblast growth factor 23 --- Klotho --- inflammation --- dermal electrochemical conductance --- neuropathy --- primary care --- screening --- sudomotor reflex --- prediabetes --- arterial stiffness --- baPWV --- aspirin --- primary prevention --- meta-analysis --- trial sequential analysis --- sCD36 --- type 1 diabetes mellitus --- branched-chain amino acids --- metabolomics --- NMR spectroscopy --- diabetic kidney disease --- reno-cardiovascular protection --- sodium-glucose co-transporter 2 inhibitors --- glucagon-like peptide-1 receptor agonists --- dipeptidyl peptidase 4 inhibitors --- obesity --- bariatric surgery --- diabetic macroangiopathy --- cardiovascular disease --- heart disease --- cerebrovascular disease --- peripheral artery disease --- diabetic foot disease --- diabetic microangiopathy --- diabetic neuropathy